Tirzepatide represents a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://aishacypz290202.blog5.net/91444567/tirzepatide-a-new-frontier-in-diabetes-treatment